Literature DB >> 10767108

The Antioxidant, N-(2-mercaptopropionyl)-glycine (MPG), Does Not Reduce Myocardial Infarct Size in an Acute Canine Model of Myocardial Ischemia and Reperfusion.

.   

Abstract

Oxygen radical generation can be measured when blood flow is restored to previously ischemic tissue. Although several studies have suggested oxygen radicals contribute to lethal injury of myocardium after ischemia, other studies have failed to confirm this implication. Antioxidants, such as N-(2-mercaptoptopionyl)-glycine (MPG) and superoxide dismutase, have had inconsistent effects on lethal myocardial injury in animal models of ischemia and reperfusion. Many variables influence lethal myocardial injury in these models: time of ischemia, time of reperfusion, dose of antioxidant, myocardial oxygen demand, area at risk, collateral blood flow, and body core temperature. The purpose of this study is to test the effects of infusion of MPG on lethal reperfusion injury in a canine model of ischemia and reperfusion with these variables tightly controlled. The left anterior descending coronary artery of anesthetized dogs was ligated for 90 minutes and reperfused for 4 hours. MPG was infused (100 mg/kg/h) 15 minutes before the end of ischemia and throughout reperfusion. Core body temperature was closely monitored, and infarct size was adjusted to transmural myocardial blood flow during ischemia. MPG had no effect on infarct size or infarct size adjusted for changes in collateral blood flow. These data reinforce a general difficulty in demonstrating the effects of antioxidant therapies on lethal injury, even when closely monitoring covariates known to impact infarct size.

Entities:  

Year:  1998        PMID: 10767108     DOI: 10.1023/A:1008830129106

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  22 in total

1.  Canine myocardial reperfusion injury: protection by a free radical scavenger, N-2-mercaptopropionyl glycine.

Authors:  S E Mitsos; J C Fantone; K P Gallagher; K M Walden; P J Simpson; G D Abrams; M A Schork; B R Lucchesi
Journal:  J Cardiovasc Pharmacol       Date:  1986 Sep-Oct       Impact factor: 3.105

2.  Myocardial reperfusion: a double-edged sword?

Authors:  E Braunwald; R A Kloner
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

3.  Reassessment of Ellman's reagent.

Authors:  P W Riddles; R L Blakeley; B Zerner
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction.

Authors:  J T Flaherty; B Pitt; J W Gruber; R R Heuser; D A Rothbaum; L R Burwell; B S George; D J Kereiakes; D Deitchman; N Gustafson
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

5.  Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.

Authors:  S R Jolly; W J Kane; M B Bailie; G D Abrams; B R Lucchesi
Journal:  Circ Res       Date:  1984-03       Impact factor: 17.367

6.  Salvage of ischaemic myocardium by reperfusion: importance of collateral blood flow and myocardial oxygen demand during occlusion.

Authors:  K Przyklenk; M T Vivaldi; F J Schoen; J Malcolm; O Arnold; R A Kloner
Journal:  Cardiovasc Res       Date:  1986-06       Impact factor: 10.787

7.  Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion.

Authors:  L D Horwitz; P V Fennessey; R H Shikes; Y Kong
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

8.  Coronary vascular injury following transient coronary artery occlusion: prevention by pretreatment with deferoxamine, dimethylthiourea and N-2-mercaptoproprionyl glycine.

Authors:  E Patterson
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

9.  "Normothermic range" temperature affects myocardial infarct size.

Authors:  G L Chien; R A Wolff; R F Davis; D M van Winkle
Journal:  Cardiovasc Res       Date:  1994-07       Impact factor: 10.787

10.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  2 in total

1.  Role of nuclear factor-kappa B activation in acute ischaemia-reperfusion injury in myocardium.

Authors:  Adrienn Kis; Derek M Yellon; Gary F Baxter
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 2.  Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.

Authors:  Andrew M Walters; George A Porter; Paul S Brookes
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.